City Therapeutics Files CITY-FXI RNAi Trial for Blood Clots
November 10, 2025
City Therapeutics, Inc., a leading biopharmaceutical company in RNA interference-based medicine, announced it has submitted a Clinical Trial Application to the UK Medicines and Healthcare